Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 64135
Gene Symbol: IFIH1
IFIH1
0.100 CausalMutation phenotype CLINVAR An extremely severe case of Aicardi-Goutières syndrome 7 with a novel variant in IFIH1. 30965144 2020
Entrez Id: 129285
Gene Symbol: PPP1R21
PPP1R21
0.300 Biomarker phenotype GENOMICS_ENGLAND Biallelic loss of function variants in PPP1R21 cause a neurodevelopmental syndrome with impaired endocytic function. 30520571 2019
Entrez Id: 2629
Gene Symbol: GBA
GBA
0.110 Biomarker phenotype BEFREE Enzyme replacement treatment (ERT) consisting of imiglucerase was initiated and was effective; WBC, Hb, and platelet count gradually normalized and the hepatosplenomegaly improved. 30456712 2019
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.020 Biomarker phenotype BEFREE Additionally, we discovered β-immunoglobulinemia and increased basal levels of G-CSF correlating with a metastatic switch, with G-CSF also promoting extramedullary hematopoiesis (both models) and causing hepatosplenomegaly (4T1 model). 30860605 2019
Entrez Id: 6609
Gene Symbol: SMPD1
SMPD1
0.020 Biomarker phenotype BEFREE Acid sphingomyelinase deficiency is an autosomal recessive sphingolipidosis, which presents with massive hepatosplenomegaly, pulmonary infiltrates, and skeletal abnormalities. 31576605 2019
Entrez Id: 27034
Gene Symbol: ACAD8
ACAD8
0.010 GeneticVariation phenotype BEFREE Here we present a case of VEO-IBD secondary to a mutation in BIRC4 gene, which encodes X-linked inhibitor of apoptosis protein (XIAP), in a 17-month-old boy with severe failure to thrive, intractable diarrhea, and hepatosplenomegaly. 31232887 2019
Entrez Id: 25
Gene Symbol: ABL1
ABL1
0.010 AlteredExpression phenotype BEFREE In a leukemic mouse model, AIC-47 greatly suppressed the increase in BCR-ABL mRNA level and improved hepatosplenomegaly regardless of the BCR-ABL mutation. 30548479 2019
Entrez Id: 199953
Gene Symbol: TMEM201
TMEM201
0.010 Biomarker phenotype BEFREE When senescence-accelerated mice (SAMP1/TA-1) with latent deterioration of immunological function and senescence-resistant control mice (SAMR1) were treated repeatedly with lipopolysaccharide, SAMP1/TA-1 mice displayed the clinicopathological features of hemophagocytic lymphohistiocytosis such as hepatosplenomegaly, pancytopenia, hypofibrinogenemia, hyperferritinemia, and hemophagocytosis. 30819910 2019
Entrez Id: 2147
Gene Symbol: F2
F2
0.010 Biomarker phenotype BEFREE It is a syndrome of unclear pathophysiology characterized by a reversible anicteric elevation of liver enzymes, alkaline phosphatase, erythrocyte sedimentation rate (ESR), thrombocytosis, prolongation of prothrombin time, and hepatosplenomegaly in the absence of direct hepatobiliary obstruction or jaundice. 31824799 2019
Entrez Id: 2630
Gene Symbol: GBAP1
GBAP1
0.010 Biomarker phenotype BEFREE Enzyme replacement treatment (ERT) consisting of imiglucerase was initiated and was effective; WBC, Hb, and platelet count gradually normalized and the hepatosplenomegaly improved. 30456712 2019
Entrez Id: 238
Gene Symbol: ALK
ALK
0.010 Biomarker phenotype BEFREE In 2008, we presented three cases of ALK-positive histiocytosis as a novel systemic histiocytic proliferation of early infancy with hepatosplenomegaly and dramatic hematological disturbances. 30573850 2019
Entrez Id: 331
Gene Symbol: XIAP
XIAP
0.010 Biomarker phenotype BEFREE Here we present a case of VEO-IBD secondary to a mutation in BIRC4 gene, which encodes X-linked inhibitor of apoptosis protein (XIAP), in a 17-month-old boy with severe failure to thrive, intractable diarrhea, and hepatosplenomegaly. 31232887 2019
Entrez Id: 3815
Gene Symbol: KIT
KIT
0.010 GeneticVariation phenotype BEFREE We describe a case of c-KIT (DV) mutation-positive fatal diffuse cutaneous mastocytosis with systemic involvement of the gastrointestinal tract and associated malabsorption and hepatosplenomegaly associated with mast cell mediator release symptoms. 30067557 2019
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.110 Biomarker phenotype BEFREE RALD was diagnosed in an 11-year-old girl following a 9-year history of severe hepatosplenomegaly and autoimmune cytopenias. 30080751 2018
Entrez Id: 537
Gene Symbol: ATP6AP1
ATP6AP1
0.100 CausalMutation phenotype CLINVAR Cutis laxa, exocrine pancreatic insufficiency and altered cellular metabolomics as additional symptoms in a new patient with ATP6AP1-CDG. 29396028 2018
Entrez Id: 4864
Gene Symbol: NPC1
NPC1
0.020 GeneticVariation phenotype BEFREE In contrast to the wild type (WT), the deletion of NPC1 alone caused significant hepatosplenomegaly, ataxia, Purkinje cell death, increased lipid storage, infertility and reduced body length and life span. 29897878 2018
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.020 Biomarker phenotype BEFREE F-FDG PET/CT demonstrated hepatosplenomegaly with marked diffuse hepatic, splenic, and bone marrow hypermetabolism. 29356737 2018
Entrez Id: 23583
Gene Symbol: SMUG1
SMUG1
0.020 Biomarker phenotype BEFREE FDG PET/CT showed generalized hypermetabolic lymph nodes, diffuse FDG uptake of the spleen, and hepatosplenomegaly mimicking lymphoma. 29863573 2018
Entrez Id: 3569
Gene Symbol: IL6
IL6
0.010 AlteredExpression phenotype BEFREE The concentration of these EVs correlated with parameters of disease including levels of serum tryptase, IL-6, and alkaline phosphatase and physical findings including hepatosplenomegaly. 30352845 2018
Entrez Id: 959
Gene Symbol: CD40LG
CD40LG
0.010 Biomarker phenotype BEFREE All residents of Olmsted County with a diagnosis of WM, consisting of a monoclonal IgM protein of any size and/or 10% or more lymphoplasmacytic infiltration of the bone marrow along with anemia, constitutional symptoms, hyperviscosity, lymphadenopathy, or hepatosplenomegaly requiring therapy, were identified from January 1, 1961, to December 31, 2010. 29656787 2018
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.120 GeneticVariation phenotype BEFREE Deletion of p16 was significantly associated with higher white blood cell count (p = 0.032) and lower platelets (p = 0.023) but was not related to age, sex, percentage of bone marrow blasts, hepatosplenomegaly, CNS leukemia rate, first complete remission and relapse rate (p > 0.05). 27967319 2017
Entrez Id: 3717
Gene Symbol: JAK2
JAK2
0.110 Biomarker phenotype BEFREE Small-molecule inhibitors of JAK2 can variably ameliorate MF-related symptoms caused by chronic inflammation and hepatosplenomegaly. 27785927 2017
Entrez Id: 10577
Gene Symbol: NPC2
NPC2
0.110 Biomarker phenotype BEFREE Our study demonstrates that NPC2 can present in early years of life with pulmonary complications like alveolar proteinosis and hepatosplenomegaly or hepatomegaly due to mutation in NPC2 gene. 28095804 2017
Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
0.010 GeneticVariation phenotype BEFREE Deletion of p16 was significantly associated with higher white blood cell count (p = 0.032) and lower platelets (p = 0.023) but was not related to age, sex, percentage of bone marrow blasts, hepatosplenomegaly, CNS leukemia rate, first complete remission and relapse rate (p > 0.05). 27967319 2017
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.010 Biomarker phenotype BEFREE Although, positivity rate of both Smad7 and TGF-β1 in ALL group increased with presence of hepatosplenomegaly, still there was no statistical significance. 28732737 2017